title: Proopiomelanocortin (POMC) mRNA expression: distribution and region-specific down-regulation by chronic morphine in female guinea pig hypothalamus.
abstract: There is compelling evidence that endogenous opioid peptides are regulated by exogenous opiates. Our previous studies have shown that the mu-opioid receptor protein and mRNA are down-regulated in the mediobasal hypothalamus of the female guinea pig following chronic morphine treatment. In addition, electrophysiological studies have shown that hypothalamic beta-endorphin (beta-EP) neurons express mu-opioid receptors that are uncoupled and down-regulated following chronic morphine treatment. Currently, we tested the hypothesis that chronic morphine, which produces down-regulation of mu-opioid receptors, causes a down-regulation of pro-opiomelanocortin (POMC, the precursor of beta-EP) mRNA expression in female guinea pig hypothalamus. Female guinea pigs were ovariectomized and implanted subcutaneously (s.c.) with 4 x 75 mg pellets for 2 days plus six more pellets of either morphine (n = 6) or placebo (n = 6) for another 5 days. Animals were sacrificed between 1000 and 1100 h on day 7. The expression of POMC mRNA were investigated using in situ hybridization histochemistry with a guinea pig specific 35S-labeled cRNA probe in hypothalamic tissue sections. POMC mRNA was localized to the arcuate nucleus (Arc) and median eminence (ME) of the medial basal hypothalamus. The distribution pattern was the same in both morphine and placebo control animals. However, the density of silver grains was less in morphine treated animals versus placebo control animals. Overall, the level of POMC mRNA was decreased by 22% in the Arc of morphine-treated guinea pigs as compared with the placebo controls (p < 0.05). This decrease in POMC mRNA expression was even greater in the caudal Arc (28%, p < 0.01) in morphine-treated animals. These results suggested that the biosynthetic activity of POMC neurons is down-regulated with chronic exposure to morphine.
authors.affiliation: Department of Physiology and Pharmacology, Oregon Health Sciences University, Portland 97201, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Fang
authors.forename: M J
authors.initials: MJ
authors.lastname: Kelly
authors.forename: O K
authors.initials: OK
authors.lastname: Rønnekleiv
mesh_terms: D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000378:metabolism; D003864:Depression, Chemical; D004343:Drug Implants; D004361:Drug Tolerance / Q000235:genetics; D005246:Feedback; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D006168:Guinea Pigs; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D007033:Hypothalamus, Middle; D017403:In Situ Hybridization; D008473:Median Eminence / Q000378:metabolism; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D010052:Ovariectomy; D011333:Pro-Opiomelanocortin / Q000096:biosynthesis / Q000235:genetics*; D012333:RNA, Messenger / Q000096:biosynthesis* / Q000235:genetics; D017450:Receptors, Opioid, mu / Q000502:physiology; D001615:beta-Endorphin / Q000096:biosynthesis / Q000235:genetics
chemical_list: D004343:Drug Implants; D012333:RNA, Messenger; D017450:Receptors, Opioid, mu; D001615:beta-Endorphin; D011333:Pro-Opiomelanocortin; D009020:Morphine